Novo Nordisk A/SNVONYSE
Loading
Net other income and expenses outside core operations
Percentile
P14
Within normal range
vs 2Y Ago
-2.1x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-4.31B | -275.2% |
| 2024 | $-1.15B | -154.7% |
| 2023 | $2.10B | +136.5% |
| 2022 | $-5.75B | -1418.1% |
| 2021 | $436.00M | +143.8% |
| 2020 | $-996.00M | +74.7% |
| 2019 | $-3.93B | -1170.8% |
| 2018 | $367.00M | +227.9% |
| 2017 | $-287.00M | +54.7% |
| 2016 | $-634.00M | - |